BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 7, 2021
View Archived Issues
New anti-EGFRvIII antibodies patented by Regeneron Pharmaceuticals
Read More
Wuhan Optics Valley Yatai Pharmaceutical Research Institute patents HIF-2-alpha inhibitors
Read More
New ROCK1/2 inhibitors identified at Wuhan LL Science and Technology Development Co.
Read More
Bayer identifies new PTGER3 antagonists
Read More
Taisho Pharmaceutical presents new MMP-2 inhibitors
Read More
Optogenetic vector GS030-DP with light stimulation shows promise in retinitis pigmentosa patient
Read More
IMC-1 improves multiple fibromyalgia symptoms
Read More
Completion of target enrollment in part A of phase I/II study of MRx-4DP0004 in asthma
Read More
Surface Oncology and Roche collaborate on immune-oncology study evaluating SRF-388 in HCC
Read More
First subjects dosed in phase II study of ADV-110 in Australia
Read More
Localized production of protein therapeutics in tumor cells using the SHREAD gene therapy platform
Read More
Genome-wide screening identifies shared and specific host factors of SARS-CoV-2 and other CoVs
Read More
Boehringer Ingelheim initiates phase I study of BI-765049 alone or in combination with BI-754091
Read More
Sorrento Therapeutics and Karolinska Institutet collaborate on iPSC-derived DAR-NK cells
Read More
BTK-selective degrader NX-5948 reduces inflammation in a murine model of rheumatoid arthritis
Read More
China's NMPA clears IND for FXR agonist ASC-42 for chronic hepatitis B
Read More
Enrollment begins in phase I study of RO-7300490 as single agent or in combination with atezolizumab
Read More
New phase I/II study evaluates AGuIX gadolinium-based nanoparticles in pancreatic and lung cancers
Read More
JMT-103 shows safety and efficacy in phase Ib/II study in patients with giant cell tumor of bone
Read More
Cardiac troponin I has predictive potential for ICU admission and mortality in COVID-19 patients
Read More
Noncovalent approach using monobodies selectively recognizes and inhibits oncogenic RAS mutants
Read More
Initial first-in-human data presented for TNO-155
Read More
New PPARgamma agonist shows promise in neurodegenerative diseases
Read More
FDA issues clinical hold letter for Ortho Regenerative Technologies' ORTHO-R
Read More
